Chongkee Yip
Affiliations: | The Chinese University of Hong Kong, Hong Kong, Hong Kong |
Area:
General EconomicsGoogle:
"Chongkee Yip"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lee YH, Tai D, Yip C, et al. (2020) Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond. Frontiers in Immunology. 11: 568759 |
| Fung SW, Fung-Yi Cheung P, Yip CW, et al. (2019) The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemo-resistance, EMT and cancer stemness in hepatocellular carcinoma. Cancer Letters |
| Yip CW, Lam CY, Poon TCW, et al. (2017) Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma. Bmc Cancer. 17: 409 |
| Cheung PF, Yip CW, Ng LW, et al. (2016) Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line. Cancer Cell International. 16: 41 |
| Cheung PF, Cheung TT, Yip CW, et al. (2016) Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma. Oncotarget |
| Cheung PF, Yip CW, Ng LW, et al. (2015) Restoration of natural killer activity in hepatocellular carcinoma by treatment with antibody against granulin-epithelin precursor. Oncoimmunology. 4: e1016706 |
| Yung MK, Lo KW, Yip CW, et al. (2015) Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer. Bmc Cancer. 15: 264 |
| Cheung PF, Yip CW, Ng LW, et al. (2014) Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo. Cancer Cell International. 14: 103 |
| Cheung PF, Yip CW, Wong NC, et al. (2014) Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity. Cancer Immunology Research. 2: 1209-19 |